AFL vs PRI: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: PRI is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AFL and PRI share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AFL and PRI exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Aflac Incorporated, headquartered in Columbus, Georgia, is the largest provider of supplemental health insurance sold at the worksite in the United States and the leading writer of cancer and medical insurance in Japan. The products are narrow by design: cash-benefit policies that pay the policyholder directly when a covered event happens (a cancer diagnosis, a hospital stay, an accident), sitting alongside rather than replacing major medical coverage. Aflac Japan, distributed through banks, independent agencies and the Japan Post network, is the larger of the two segments and produced pretax adjusted earnings of ~$759 million in Q1 2026 against ~$363 million for Aflac US. Because premiums are small, recurring and paid by payroll deduction or bank draft, the revenue base is unusually stable compared with property, casualty or annuity writers.

Full AFL guide

Primerica sells simple term life insurance it underwrites itself, plus mutual funds, managed accounts, annuities, segregated funds and brokered mortgages that other firms manufacture. What makes the company unusual is the distribution: about 148,600 life-licensed independent representatives, most of them working part time and recruited from the same middle-income communities they sell into. Three segments carry the results. Term Life Insurance produced roughly $444 million of adjusted operating revenue and about $148 million of pre-tax income in the second quarter of 2026, a 21.3% segment margin off an in-force block built up over decades. Investment and Savings Products (ISP) produced about $361 million of revenue and $104 million of pre-tax income on record quarterly sales of roughly $4.4 billion. Corporate and Other Distributed Products, which includes mortgage brokerage and net investment income, adds a small remainder. The Senior Health segment, built around the e-TeleQuote Medicare brokerage acquired in 2021, was exited in 2024 and no longer appears in the segment tables.

Full PRI guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• AFL drivers: Japan third-sector product refresh; Buyback-driven earnings per share.
• PRI drivers: The investment and savings flywheel; The in-force term life book as the cash engine.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The dominant risk is the yen: with the majority of profit earned in Japan, a weaker yen compresses reported dollar earnings and book value even when the underlying business is unchanged, and the enterprise hedging program reduces but does not eliminate the effect. For PRI, the clearest risk is the distribution model itself, because a life-licensed force that shrinks 3% a year eventually shows up in issued policies, then in in-force premium, then in Term Life earnings.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick AFL if you believe its drivers more; PRI if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AFL and PRI guides.

AFL. Aflac's reported revenue line is noisier than the underlying business because it absorbs net investment gains and losses and yen translation, which is why 2025 revenue fell while adjusted earnings per share rose. The market has generally valued the stock in the low-to-mid teens on earnings, a discount to the broad market that reflects the shrinking Japanese premium base and the currency exposure, offset by high margins and heavy buybacks. Q2 2026 results were scheduled for release after the close on August 6, 2026, with consensus near ~$1.77 in adjusted EPS on ~$4.19 billion of revenue.

PRI. Trailing twelve-month revenue of about $3.43 billion and net income near $796 million work out to roughly $24.90 of diluted earnings per share, which puts the stock around 12 times trailing earnings at a share price in the high $290s. Book value is about $2.52 billion on roughly 30.9 million shares, or close to $82 per share, so the multiple of book sits near 3.7 times, a premium that reflects reported return on equity of 32.1% rather than an insurer-style balance sheet story. Screeners sometimes carry a stale Senior Health segment or a depressed 2024 earnings base, since the e-TeleQuote exit pushed second-quarter 2024 net income to roughly $1 million; the FY2025 figures of $3.29 billion revenue and $22.91 diluted EPS are the cleaner comparison.

Headline figures (approximate, August 2026): AFL shows revenue (ttm) ~$18.2 billion (FY2025 was ~$17.2 billion, down ~9.3% year over year), net earnings (ttm) ~$4.6 billion; Q1 2026 net earnings were ~$1.0 billion, or ~$1.98 per diluted share, adjusted eps ~$7.49 for FY2025; Q1 2026 adjusted EPS was ~$1.75, up ~5.4% year over year, market cap / p/e (ttm) ~$63 billion at a share price near ~$124, or roughly ~14x trailing earnings of ~$8.75 per share; PRI shows revenue (ttm) ~$3.43B, net income (ttm) ~$796M (~23% net margin), diluted eps (ttm) ~$24.90, market cap / p/e ~$9.2B / ~12x trailing.

AFL and PRI are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AFL and PRI exposure against your real portfolio. It is not an investment adviser.